Abstract

BackgroundDetailed descriptions of the patterns of disease progression of deceased coronavirus disease 2019 (COVID‐19) patients have not been well explored.ObjectivesThis study sought to explore disease progression patterns and risk factors associated with mortality of deceased patients with COVID‐19.Materials and MethodsEpidemiological, clinical, laboratory, and imaging data (from 15 January to 26 March 2020) of laboratory‐confirmed COVID‐19 patients were collected retrospectively from two hospitals, Hubei province, China. Disease progression patterns of patients were analyzed based on laboratory data, radiological findings, and Sequential Organ Failure Assessment (SOFA) score. Risk factors associated with death were analyzed.ResultsA total of 792 patients were enrolled in this study, of whom 68 died and 724 survived. Complications during hospitalization, such as sepsis, severe acute respiratory distress syndrome, acute cardiac injury, and acute kidney injury, were markedly more frequent in deceased patients than in surviving patients. Deceased patients presented progressive deterioration pattern in laboratory variables, chest computed tomography evaluation, and SOFA score, while surviving patients presented initial deterioration to peak level involvement followed by improvement pattern over time. Days 10 to 14 after illness onset was a critical stage of disease course. Older age, number of preexisting comorbidities ≥2, and SOFA score were independently associated with death for COVID‐19.ConclusionsMultiorgan dysfunction was common in deceased COVID‐19 patients. Deceased patients presented progressive deterioration pattern, while surviving patients presented a relatively stable pattern during disease progression. Older age, number of preexisting comorbidities ≥2, and SOFA score were independent risk factors for death for COVID‐19.

Highlights

  • A novel coronavirus infection‐related pneumonia was first reported in Wuhan, Hubei Province, China in December 2019.1,2 Coronaviruses are enveloped RNA viruses that are distributed broadly in humans and other mammals, and cause diseases involving multiple systems.[3]

  • Similar to the two other coronavirus—severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, the novel coronavirus, which has been named severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) by the International Committee on Taxonomy of Viruses on 11 February 2020,4 can lead to severe acute respiratory distress syndrome (ARDS) in humans.[5]

  • This was a retrospective study on the patterns of disease progression in laboratory tests, chest computed tomography (CT) scans, and Sequential Organ Failure Assessment (SOFA) score in deceased and surviving patients with COVID‐19, as well as risk factors for death for COVID‐19

Read more

Summary

Introduction

A novel coronavirus infection‐related pneumonia was first reported in Wuhan, Hubei Province, China in December 2019.1,2 Coronaviruses are enveloped RNA viruses that are distributed broadly in humans and other mammals, and cause diseases involving multiple systems.[3]. Chest CT findings of patients with COVID‐19 have been reported.[9,10] In addition, the Sequential Organ Failure Assessment (SOFA) score has been proposed as a useful scoring tool to determine the level of organ dysfunction and mortality risk by the Sepsis‐3.0 version in 2016.11 patterns of disease progression of deceased patients with COVID‐19 have not been thoroughly described. The aim of this study was to investigate disease progression pattern of deceased patients with COVID‐19 by laboratory data, radiological findings, and SOFA score, as well as analyze risk factors for in‐hospital death, to improve overall understanding for COVID‐19. Disease progression patterns of patients were analyzed based on laboratory data, radiological findings, and Sequential Organ Failure Assessment (SOFA) score. Deceased patients presented progressive deterioration pattern in laboratory variables, chest computed tomography evaluation, and SOFA score, while surviving patients presented initial deterioration to peak level involvement followed by improvement pattern over time. Deceased patients presented progressive deterioration pattern, while surviving patients presented a relatively stable pattern during disease [Correction added on 05 November 2020, after first online publication: Projekt Deal funding statement has been added.]

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call